Insider · CIK 0001201196

SAYARE MITCHEL

Reports to the SEC for 2 companies · GAITHERSBURG, MD

sec.gov

Transactions

Companies

Filings

CIK

0001201196

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-01	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+48.8K sh	—	—	48,800
2025-09-25	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+48.8K sh	—	—	48,800
2024-09-26	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+34.9K sh	—	—	34,900
2023-09-28	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+26.1K sh	—	—	26,100
2022-09-29	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+23.5K sh	—	—	23,500
2021-09-23	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+24.1K sh	—	—	24,100
2020-09-24	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+25.3K sh	—	—	26,363
2020-09-24	ALTAltimmune, Inc. · Restricted Stock Units ("RSUs")M Exercise/Conversion	Director	MExercise/Conversion	−25.3K sh	—	—	0
2020-09-24	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+25.5K sh	—	—	25,500
2020-06-25	ALTAltimmune, Inc. · Restricted Stock Units ("RSUs")A Award	Director	AAward	+25.3K sh	—	—	25,275
2019-01-02	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2018-04-05	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2017-12-29	ALTAltimmune, Inc.P Purchase	Director	PPurchase	+5,100 sh	$1.95	+$9,962.85	32,650
2017-10-13	ALTAltimmune, Inc. · Stock Options (option to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.52	+$30.4K	25,000
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.60	+$32K	45,000
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+60K sh	$2.67	+$160K	105,000
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+52.1K sh	$2.67	+$139K	157,139
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.45	+$29K	177,139
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.64	+$32.8K	197,139
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.51	+$30.2K	217,139
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+18.4K sh	$1.81	+$33.2K	235,500
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$1.69	+$33.8K	255,500
2016-11-22	ALTAltimmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+20K sh	$2.20	+$44K	275,500
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−60K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−52.1K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−18.4K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-11-22	ALTAltimmune, Inc. · Stock option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−20K sh	—	—	0
2016-06-01	ALTAltimmune, Inc. · Stock option (right to buy)A Award	Director	AAward	+20K sh	$2.20	+$44K	20,000
2015-08-02	ALTAltimmune, Inc. · Stock options (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2014-12-31	ALTAltimmune, Inc. · Stock options (right to buy)A Award	Director	AAward	+18.4K sh	—	—	18,361
2013-06-11	ALTAltimmune, Inc. · Stock option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2012-06-22	ALTAltimmune, Inc. · Stock option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-08-18	ALTAltimmune, Inc.P Purchase	Director	PPurchase	+5,000 sh	$2.17	+$10.9K	5,000
2011-07-29	ImmunoGen, Inc.S Sale	Director	SSale	−10K sh	$13.25	−$133K	383,136
2011-07-17	ALTAltimmune, Inc. · Stock option (right to buy)A Award	Director	AAward	+52.1K sh	—	—	52,139
2011-07-15	ImmunoGen, Inc.S Sale	Director	SSale	−10K sh	$15.02	−$150K	393,136
2011-07-15	ALTAltimmune, Inc. · Stock option (right to buy)A Award	Director	AAward	+60K sh	—	—	60,000
2011-06-24	ImmunoGen, Inc.S Sale	Director	SSale	−10K sh	$11.70	−$117K	403,136
2011-06-23	ALTAltimmune, Inc. · Stock option (right to buy)A Award	Director	AAward	+20K sh	—	—	20,000
2011-06-10	ImmunoGen, Inc.S Sale	Director	SSale	−10K sh	$11.69	−$117K	413,136
2011-05-27	ImmunoGen, Inc.S Sale	Director	SSale	−10K sh	$12.24	−$122K	423,136
2011-05-13	ImmunoGen, Inc.S Sale	Director	SSale	−10K sh	$13.23	−$132K	433,136
2011-04-29	ImmunoGen, Inc.S Sale	Director	SSale	−20K sh	$13.28	−$266K	443,136

Recent filings

Accepted (ET)
May 14
SAYARE MITCHEL0001201196-26-000002
SEC(opens sec.gov)
Sep 294
SAYARE MITCHEL0001104659-25-094488
SEC(opens sec.gov)
Sep 304
SAYARE MITCHEL0001104659-24-104441
SEC(opens sec.gov)
Sep 294
SAYARE MITCHEL0001104659-23-105390
SEC(opens sec.gov)
Sep 304
SAYARE MITCHEL0001104659-22-104776
SEC(opens sec.gov)
Sep 244
SAYARE MITCHEL0001104659-21-119488
SEC(opens sec.gov)
Oct 164
SAYARE MITCHEL0000899243-20-028540
SEC(opens sec.gov)
Sep 284
SAYARE MITCHEL0000899243-20-026414
SEC(opens sec.gov)
Jun 294
SAYARE MITCHEL0000899243-20-017824
SEC(opens sec.gov)
Jan 44
SAYARE MITCHEL0001012975-19-000041
SEC(opens sec.gov)
Apr 64
SAYARE MITCHEL0001012975-18-000335
SEC(opens sec.gov)
Jan 34
SAYARE MITCHEL0001012975-18-000023
SEC(opens sec.gov)
Oct 174
SAYARE MITCHEL0001012975-17-000771
SEC(opens sec.gov)
Nov 234
PHARMATHENE, INC0001144204-16-136387
SEC(opens sec.gov)

Companies

Address

910 CLOPPER ROAD SUITE 201S

GAITHERSBURG, MD, 20878